A
$ Value
$0
Shares
184,878
Price
$0
Filed
Jun 17
Insider
Name
Hare Joshua
Title
Chief Scientific Officer
CIK
0001449392
Roles
Director
Officer
10% Owner
Transaction Details
Transaction Date
2025-06-13
Code
A
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
184,878
Footnotes
The option will 100% cliff vest on July 1, 2025. The option was administratively granted on April 11, 2025 contingent on the approval by the Company's stockholders of an amendment to the Company's 2021 Incentive Award Plan (as amended and restated to date) (the "Plan") to increase the number of shares available for awards under the Plan at the 2025 Annual Meeting of Stockholders held on June 13, 2025 (the "Annual Meeting"). This stockholder approval contingency was satisfied upon approval of the share increase at the Annual Meeting.
Filing Info
Hare Joshua's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2025-07-15 | LGVN | A | $0 |
| 2025-07-01 | LGVN | A | $0 |
| 2025-06-13 | LGVN | A | $0 |
| 2025-06-13 | LGVN | A | $0 |
| 2025-05-16 | LGVN | ▼ | $7K |
Other Insiders at LGVN (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Willard Stephen H
Chief Executive Officer
|
— | — | 2026-04-01 |
|
Lehr Paul T
General Counsel, Secretary
|
— | — | 2026-04-01 |
|
Agafonova Nataliya
Chief Medical Officer
|
— | — | 2026-04-01 |
|
Locklear Lisa
Chief Financial Officer
|
— | — | 2026-04-01 |
|
Blass Devin
CTO & SVP of CMC
|
— | — | 2026-04-01 |